Proteomics International Seeks Up to $5 Million in Discounted Share Plan
PIQ: $0.091 -24.17% · MC: $16M
Proteomics International Laboratories is seeking up to $5 million before costs through a share purchase plan, equivalent to about a quarter of its recent market capitalisation. The offer price is $0.10 per share, a discount of approximately 17% to the previous closing price, with a free option for each share subject to shareholder approval. The proposed funding is intended to support commercialisation, clinical and reimbursement work, product launches and US market preparations. The company recently began the national rollout of its Promarker D and Promarker Eso tests through Healius.

Comments